Brand Name for Formoterol
The brand name for formoterol (a long-acting beta agonist) is Foradil Aerolizer. 1
Formoterol Overview
Formoterol is a selective long-acting beta2-adrenergic receptor agonist (LABA) that provides significant bronchodilation for up to 12 hours following a single dose. It is available under the brand name Foradil Aerolizer as indicated in the FDA drug label 1.
Key Characteristics:
- Duration of action: More than 12 hours 2
- Onset of action: Rapid onset (significant bronchodilation within minutes of inhalation) 3
- Specificity: Very specific for β-adrenergic receptors with low rates of tremor and palpitations 2
Clinical Applications
Formoterol (Foradil) is FDA-approved for:
Asthma treatment:
- Only as concomitant therapy with a long-term asthma control medication (such as an inhaled corticosteroid)
- For adults and children 5 years of age and older with reversible obstructive airways disease 1
Exercise-induced bronchospasm (EIB):
- For acute prevention of EIB in adults and children 5 years and older
- Can be used on an occasional, as-needed basis 1
Chronic Obstructive Pulmonary Disease (COPD):
- For long-term, twice daily maintenance treatment of bronchoconstriction
- Includes patients with chronic bronchitis and emphysema 1
Important Safety Considerations
Black Box Warning
Long-acting beta2-agonists like formoterol increase the risk of asthma-related death. Therefore:
- Never use formoterol as monotherapy for asthma treatment
- Always use in combination with a long-term asthma control medication (e.g., inhaled corticosteroid)
- Once asthma control is achieved, consider stepping down therapy if possible 1
Pediatric and Adolescent Patients
For pediatric and adolescent patients requiring a LABA in addition to an inhaled corticosteroid, a fixed-dose combination product containing both medications is generally preferred to ensure adherence with both components 1.
Formulation and Delivery
Foradil is delivered via the Aerolizer device as a dry powder inhalation 1, 4. A newer formulation called Foradil Certihaler, which utilizes a multidose dry-powder inhaler device, has also been developed 5.
Clinical Differentiation from Other LABAs
When comparing formoterol to salmeterol (another LABA):
- Formoterol achieves significant bronchodilation more rapidly than salmeterol
- Both medications have similar duration of bronchodilation (approximately 12 hours) 3, 6
Formoterol is also available as arformoterol (R,R-formoterol), which is a single isomer form of formoterol developed by Sepracor for respiratory disorders 7.